184 related articles for article (PubMed ID: 17298226)
1. Ursodesoxycholic acid and heme-arginate are unable to improve hematopoiesis and liver injury in an erythropoietic protoporphyria mouse model.
Abitbol M; Puy H; Sabaté JM; Guénet JL; Deybach JC; Montagutelli X
Physiol Res; 2006; 55 Suppl 2():S93-101. PubMed ID: 17298226
[TBL] [Abstract][Full Text] [Related]
2. Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria.
Meerman L; Koopen NR; Bloks V; Van Goor H; Havinga R; Wolthers BG; Kramer W; Stengelin S; Müller M; Kuipers F; Jansen PL
Gastroenterology; 1999 Sep; 117(3):696-705. PubMed ID: 10464147
[TBL] [Abstract][Full Text] [Related]
3. Hepatic gene expression in protoporphyic Fech mice is associated with cholestatic injury but not a marked depletion of the heme regulatory pool.
Davies R; Schuurman A; Barker CR; Clothier B; Chernova T; Higginson FM; Judah DJ; Dinsdale D; Edwards RE; Greaves P; Gant TW; Smith AG
Am J Pathol; 2005 Apr; 166(4):1041-53. PubMed ID: 15793285
[TBL] [Abstract][Full Text] [Related]
4. Liver metabolomics in a mouse model of erythropoietic protoporphyria.
Wang P; Sachar M; Guo GL; Shehu AI; Lu J; Zhong XB; Ma X
Biochem Pharmacol; 2018 Aug; 154():474-481. PubMed ID: 29906468
[TBL] [Abstract][Full Text] [Related]
5. Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice.
Barman-Aksözen J; C Wiek P; Bansode VB; Koentgen F; Trüb J; Pelczar P; Cinelli P; Schneider-Yin X; Schümperli D; Minder EI
Dis Model Mech; 2017 Mar; 10(3):225-233. PubMed ID: 28093505
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietic Protoporphyria: Initial Diagnosis With Cholestatic Liver Disease.
Coffey A; Leung DH; Quintanilla NM
Pediatrics; 2018 Apr; 141(Suppl 5):S445-S450. PubMed ID: 29610169
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietic protoporphyria.
Lecha M; Puy H; Deybach JC
Orphanet J Rare Dis; 2009 Sep; 4():19. PubMed ID: 19744342
[TBL] [Abstract][Full Text] [Related]
8. Neonatal bone marrow transplantation prevents liver disease in a murine model of erythropoietic protoporphyria.
Duchartre Y; Petit N; Moya C; Lalanne M; Dubus P; Verneuil Hd; Moreau-Gaudry F; Richard E
J Hepatol; 2011 Jul; 55(1):162-70. PubMed ID: 21145811
[TBL] [Abstract][Full Text] [Related]
9. [Inheritance in erythropoietic protoporphyria].
Schmitt C; Ducamp S; Gouya L; Deybach JC; Puy H
Pathol Biol (Paris); 2010 Oct; 58(5):372-80. PubMed ID: 20850938
[TBL] [Abstract][Full Text] [Related]
10. Beyond pigmentation: signs of liver protection during afamelanotide treatment in Swiss patients with erythropoietic protoporphyria, an observational study.
Minder AE; Barman-Aksoezen J; Schmid M; Minder EI; Zulewski H; Minder CE; Schneider-Yin X
Ther Adv Rare Dis; 2021; 2():26330040211065453. PubMed ID: 37181106
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietic Protoporphyria and X-Linked Protoporphyria: pathophysiology, genetics, clinical manifestations, and management.
Balwani M
Mol Genet Metab; 2019 Nov; 128(3):298-303. PubMed ID: 30704898
[TBL] [Abstract][Full Text] [Related]
12. Liver disease and erythropoietic protoporphyria: a concise review.
Casanova-González MJ; Trapero-Marugán M; Jones EA; Moreno-Otero R
World J Gastroenterol; 2010 Sep; 16(36):4526-31. PubMed ID: 20857522
[TBL] [Abstract][Full Text] [Related]
13. Mild iron deficiency does not ameliorate the phenotype of a murine erythropoietic protoporphyria model.
Schmidt PJ; Hollowell ML; Fitzgerald K; Butler JS; Fleming MD
Am J Hematol; 2020 May; 95(5):492-496. PubMed ID: 31990410
[TBL] [Abstract][Full Text] [Related]
14. Increased mitochondrial respiratory chain enzyme activities correlate with minor extent of liver damage in mice suffering from erythropoietic protoporphyria.
Navarro S; Del Hoyo P; Campos Y; Abitbol M; Morán-Jiménez MJ; García-Bravo M; Ochoa P; Grau M; Montagutelli X; Frank J; Garesse R; Arenas J; de Salamanca RE; Fontanellas A
Exp Dermatol; 2005 Jan; 14(1):26-33. PubMed ID: 15660916
[TBL] [Abstract][Full Text] [Related]
15. A mouse model provides evidence that genetic background modulates anemia and liver injury in erythropoietic protoporphyria.
Abitbol M; Bernex F; Puy H; Jouault H; Deybach JC; Guénet JL; Montagutelli X
Am J Physiol Gastrointest Liver Physiol; 2005 Jun; 288(6):G1208-16. PubMed ID: 15677551
[TBL] [Abstract][Full Text] [Related]
16. Inheritance in erythropoietic protoporphyria: a common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation.
Gouya L; Puy H; Lamoril J; Da Silva V; Grandchamp B; Nordmann Y; Deybach JC
Blood; 1999 Mar; 93(6):2105-10. PubMed ID: 10068685
[TBL] [Abstract][Full Text] [Related]
17. Cholestyramine resin for erythropoietic protoporphyria with severe hepatic disease: a case report.
Yoo DJ; Lee HC; Yu E; Jin YJ; Shim JH; Kim KM; Lim YS; Chung YH; Lee YS; Suh DJ
Korean J Hepatol; 2010 Mar; 16(1):83-8. PubMed ID: 20375647
[TBL] [Abstract][Full Text] [Related]
18. Congenital erythropoietic porphyria and erythropoietic protoporphyria: Identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations.
Weiss Y; Balwani M; Chen B; Yasuda M; Nazarenko I; Desnick RJ
Mol Genet Metab; 2019 Nov; 128(3):358-362. PubMed ID: 30454868
[TBL] [Abstract][Full Text] [Related]
19. Reversion of hepatobiliary alterations By bone marrow transplantation in a murine model of erythropoietic protoporphyria.
Fontanellas A; Mazurier F; Landry M; Taine L; Morel C; Larou M; Daniel JY; Montagutelli X; de Salamanca RE; de Verneuil H
Hepatology; 2000 Jul; 32(1):73-81. PubMed ID: 10869291
[TBL] [Abstract][Full Text] [Related]
20. How I treat erythropoietic protoporphyria and X-linked protoporphyria.
Leaf RK; Dickey AK
Blood; 2023 Jun; 141(24):2921-2931. PubMed ID: 36898083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
